The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus
Objective: Intestinal inflammation triggers postoperative ileus (POI), commonly seen after abdominal surgery and characterized by impaired gastrointestinal transit; when prolonged, this leads to increased morbidity. Hydrogen sulfide (H2S) is recognized as an important mediator of many (patho)physiol...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2019-02-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00116/full |
| _version_ | 1819326887472660480 |
|---|---|
| author | Jonas Van Dingenen Leen Pieters Anne Vral Romain A. Lefebvre |
| author_facet | Jonas Van Dingenen Leen Pieters Anne Vral Romain A. Lefebvre |
| author_sort | Jonas Van Dingenen |
| collection | DOAJ |
| description | Objective: Intestinal inflammation triggers postoperative ileus (POI), commonly seen after abdominal surgery and characterized by impaired gastrointestinal transit; when prolonged, this leads to increased morbidity. Hydrogen sulfide (H2S) is recognized as an important mediator of many (patho)physiological processes, including inflammation, and is now investigated for anti-inflammatory application. Therefore, the aim of this study was to investigate the effect of the H2S-releasing naproxen derivative ATB-346, developed to reduce gastrointestinal injury by naproxen, and the slow-release H2S donor GYY4137 on intestinal inflammation and delayed gastrointestinal transit in murine POI.Methods: C57Bl6J mice were fasted for 6 h, anesthetized and after laparotomy, POI was induced by compressing the small intestine with two cotton applicators for 5 min (intestinal manipulation; IM). GYY4137 (50 mg/kg, intraperitoneally), ATB-346 (16 mg/kg, intragastrically) or naproxen (10 mg/kg, intragastrically) were administered 1 h before IM. At 24 h postoperatively, gastrointestinal transit was assessed via fluorescent imaging, and mucosa-free muscularis segments were prepared for later analysis. Inflammatory parameters and activity of inducible nitric oxide synthase (iNOS) and cyclo-oxygenase (COX)-2 were measured. Histological examination of whole tissue sections was done on hematoxylin-eosin stained slides.Results: Pre-treatment with GYY4137 (geometric center; GC: 7.6 ± 0.5) and ATB-346 (GC: 8.4 ± 0.3) prevented the delayed transit induced by IM (GC: 3.6 ± 0.5 vs. 9.0 ± 0.4 in non-operated controls) while naproxen only partially did (GC: 5.9 ± 0.5; n = 8 for all groups). GYY4137 and ATB-346 significantly reduced the IM-induced increase in muscular myeloperoxidase (MPO) activity and protein levels of interleukin (IL)-6, IL-1β and monocyte chemotactic protein 1; the reduction by naproxen was less pronounced and only reached significance for MPO activity and IL-6 levels. All treatments significantly reduced the increase in COX-2 activity caused by IM, whereas only GYY4137 significantly reduced the increase in iNOS activity. Naproxen treatment caused significant histological damage of intestinal villi.Conclusion: The study shows that naproxen partially prevents POI, probably through its inhibitory effect on COX-2 activity. Both ATB-346 and GYY4137 were more effective, the result with GYY4137 showing that H2S per se can prevent POI. |
| first_indexed | 2024-12-24T13:02:05Z |
| format | Article |
| id | doaj.art-ac1e3c592d954a4d92a7482ec7581fed |
| institution | Directory Open Access Journal |
| issn | 1663-9812 |
| language | English |
| last_indexed | 2024-12-24T13:02:05Z |
| publishDate | 2019-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Pharmacology |
| spelling | doaj.art-ac1e3c592d954a4d92a7482ec7581fed2022-12-21T16:54:07ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-02-011010.3389/fphar.2019.00116437996The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative IleusJonas Van Dingenen0Leen Pieters1Anne Vral2Romain A. Lefebvre3Department of Basic and Applied Medical Sciences, Heymans Institute of Pharmacology, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumDepartment of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumDepartment of Human Structure and Repair, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumDepartment of Basic and Applied Medical Sciences, Heymans Institute of Pharmacology, Faculty of Medicine and Health Sciences, Ghent University, Ghent, BelgiumObjective: Intestinal inflammation triggers postoperative ileus (POI), commonly seen after abdominal surgery and characterized by impaired gastrointestinal transit; when prolonged, this leads to increased morbidity. Hydrogen sulfide (H2S) is recognized as an important mediator of many (patho)physiological processes, including inflammation, and is now investigated for anti-inflammatory application. Therefore, the aim of this study was to investigate the effect of the H2S-releasing naproxen derivative ATB-346, developed to reduce gastrointestinal injury by naproxen, and the slow-release H2S donor GYY4137 on intestinal inflammation and delayed gastrointestinal transit in murine POI.Methods: C57Bl6J mice were fasted for 6 h, anesthetized and after laparotomy, POI was induced by compressing the small intestine with two cotton applicators for 5 min (intestinal manipulation; IM). GYY4137 (50 mg/kg, intraperitoneally), ATB-346 (16 mg/kg, intragastrically) or naproxen (10 mg/kg, intragastrically) were administered 1 h before IM. At 24 h postoperatively, gastrointestinal transit was assessed via fluorescent imaging, and mucosa-free muscularis segments were prepared for later analysis. Inflammatory parameters and activity of inducible nitric oxide synthase (iNOS) and cyclo-oxygenase (COX)-2 were measured. Histological examination of whole tissue sections was done on hematoxylin-eosin stained slides.Results: Pre-treatment with GYY4137 (geometric center; GC: 7.6 ± 0.5) and ATB-346 (GC: 8.4 ± 0.3) prevented the delayed transit induced by IM (GC: 3.6 ± 0.5 vs. 9.0 ± 0.4 in non-operated controls) while naproxen only partially did (GC: 5.9 ± 0.5; n = 8 for all groups). GYY4137 and ATB-346 significantly reduced the IM-induced increase in muscular myeloperoxidase (MPO) activity and protein levels of interleukin (IL)-6, IL-1β and monocyte chemotactic protein 1; the reduction by naproxen was less pronounced and only reached significance for MPO activity and IL-6 levels. All treatments significantly reduced the increase in COX-2 activity caused by IM, whereas only GYY4137 significantly reduced the increase in iNOS activity. Naproxen treatment caused significant histological damage of intestinal villi.Conclusion: The study shows that naproxen partially prevents POI, probably through its inhibitory effect on COX-2 activity. Both ATB-346 and GYY4137 were more effective, the result with GYY4137 showing that H2S per se can prevent POI.https://www.frontiersin.org/article/10.3389/fphar.2019.00116/fullATB-346GYY4137hydrogen sulfidenaproxenpostoperative ileus |
| spellingShingle | Jonas Van Dingenen Leen Pieters Anne Vral Romain A. Lefebvre The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus Frontiers in Pharmacology ATB-346 GYY4137 hydrogen sulfide naproxen postoperative ileus |
| title | The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus |
| title_full | The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus |
| title_fullStr | The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus |
| title_full_unstemmed | The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus |
| title_short | The H2S-Releasing Naproxen Derivative ATB-346 and the Slow-Release H2S Donor GYY4137 Reduce Intestinal Inflammation and Restore Transit in Postoperative Ileus |
| title_sort | h2s releasing naproxen derivative atb 346 and the slow release h2s donor gyy4137 reduce intestinal inflammation and restore transit in postoperative ileus |
| topic | ATB-346 GYY4137 hydrogen sulfide naproxen postoperative ileus |
| url | https://www.frontiersin.org/article/10.3389/fphar.2019.00116/full |
| work_keys_str_mv | AT jonasvandingenen theh2sreleasingnaproxenderivativeatb346andtheslowreleaseh2sdonorgyy4137reduceintestinalinflammationandrestoretransitinpostoperativeileus AT leenpieters theh2sreleasingnaproxenderivativeatb346andtheslowreleaseh2sdonorgyy4137reduceintestinalinflammationandrestoretransitinpostoperativeileus AT annevral theh2sreleasingnaproxenderivativeatb346andtheslowreleaseh2sdonorgyy4137reduceintestinalinflammationandrestoretransitinpostoperativeileus AT romainalefebvre theh2sreleasingnaproxenderivativeatb346andtheslowreleaseh2sdonorgyy4137reduceintestinalinflammationandrestoretransitinpostoperativeileus AT jonasvandingenen h2sreleasingnaproxenderivativeatb346andtheslowreleaseh2sdonorgyy4137reduceintestinalinflammationandrestoretransitinpostoperativeileus AT leenpieters h2sreleasingnaproxenderivativeatb346andtheslowreleaseh2sdonorgyy4137reduceintestinalinflammationandrestoretransitinpostoperativeileus AT annevral h2sreleasingnaproxenderivativeatb346andtheslowreleaseh2sdonorgyy4137reduceintestinalinflammationandrestoretransitinpostoperativeileus AT romainalefebvre h2sreleasingnaproxenderivativeatb346andtheslowreleaseh2sdonorgyy4137reduceintestinalinflammationandrestoretransitinpostoperativeileus |